The 2024 Pharmacy Benefit Manager Customer Satisfaction Report published by Pharmaceutical Strategies Group ("PSG") disclosed ...

SAN DIEGO - MEI Pharma, Inc. (NASDAQ:MEIP), a clinical-stage pharmaceutical company, announced that it is continuing to evaluate strategic alternatives to maximize shareholder value, including ...

Getting more effective drugs for patients in need as quickly as possible should be the ultimate reward and objective.

NEWTOWN, PA — Traws Pharma, Inc. (Nasdaq: TRAW) recently announced a pivotal shift in its board with the appointment of Luba ...

Meanwhile, MEI Pharma has enlisted Oppenheimer for a strategic review to optimize shareholder value. This comes after the pharmaceutical company announced significant leadership changes and strategic ...

The climate crisis is already impacting nearly every therapeutic area, according to a new report. Pharma marketers are ...

In a bid to break down barriers facing both pharmas and payers in the life sciences industry, AscellaHealth has begun ...

Collaboration between giant pharmaceutical corporations and patients with very little power just doesn’t work, according to ...

Patients for Affordable Drugs (“P4AD”) became the latest amicus to file a brief with the U.S. Court of Appeals for the Third ...